Evidence map›Paper›PMID 26889029›Full record

ArticleJournal of virology2016

The Proteolytic Activation of (H3N2) Influenza A Virus Hemagglutinin Is Facilitated by Different Type II Transmembrane Serine Proteases.

Nora Kühn, Silke Bergmann, Nadine Kösterke, Ruth L O Lambertz, Anna Keppner, Judith M A van den Brand, Stefan Pöhlmann, Siegfried Weiß, Edith Hummler, Bastian Hatesuer and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Finding proteases that make cells go viral.The Journal of biological chemistry · 2020
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Nora KühnDepartment of Infection Genetics, Helmholtz Centre for Infection Research, and University of Veterinary Medicine Hannover, Braunschweig, Germany.
Silke BergmannDepartment of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Nadine KösterkeDepartment of Molecular Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Ruth L O LambertzDepartment of Infection Genetics, Helmholtz Centre for Infection Research, and University of Veterinary Medicine Hannover, Braunschweig, Germany.
Anna KeppnerDepartment of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland.
Judith M A van den BrandDepartment of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands.
Stefan PöhlmannInfection Biology Unit, German Primate Center, Göttingen, Germany.ORCID http://orcid.org/0000-0001-6086-9136
Siegfried WeißDepartment of Molecular Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Edith HummlerDepartment of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland.
Bastian HatesuerDepartment of Infection Genetics, Helmholtz Centre for Infection Research, and University of Veterinary Medicine Hannover, Braunschweig, Germany.
Klaus SchughartDepartment of Infection Genetics, Helmholtz Centre for Infection Research, and University of Veterinary Medicine Hannover, Braunschweig, Germany klaus.schughart@helmholtz-hzi.de.
University of Veterinary Medicine Hannover, Foundation · DEHelmholtz Centre for Infection Research · DEUniversity of Lausanne · CHUniversity of Tennessee Health Science Center · USGerman Primate Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledCleavage of influenza virus hemagglutinin (HA) by host cell proteases is necessary for viral activation and infectivity. In humans and mice, members of the type II transmembrane protease family (TTSP), e.g., TMPRSS2, TMPRSS4, and TMPRSS11d (HAT), have been shown to cleave influenza virus HA for viral activation and infectivity in vitro Recently, we reported that inactivation of a single HA-activating protease gene,Tmprss2, in knockout mice inhibits the spread of H1N1 influenza viruses. However, after infection of Tmprss2 knockout mice with an H3N2 influenza virus, only a slight increase in survival was observed, and mice still lost body weight. In this study, we investigated an additional trypsin-like protease, TMPRSS4. Both TMPRSS2 and TMPRSS4 are expressed in the same cell types of the mouse lung. Deletion of Tmprss4 alone in knockout mice does not protect them from body weight loss and death upon infection with H3N2 influenza virus. In contrast,Tmprss2(-/-)Tmprss4(-/-)double-knockout mice showed a remarkably reduced virus spread and lung pathology, in addition to reduced body weight loss and mortality. Thus, our results identified TMPRSS4 as a second host cell protease that, in addition to TMPRSS2, is able to activate the HA of H3N2 influenza virus in vivo IMPORTANCE: Influenza epidemics and recurring pandemics are responsible for significant global morbidity and mortality. Due to high variability of the virus genome, resistance to available antiviral drugs is frequently observed, and new targets for treatment of influenza are needed. Host cell factors essential for processing of the virus hemagglutinin represent very suitable drug targets because the virus is dependent on these host factors for replication. We reported previously that Tmprss2-deficient mice are protected against H1N1 virus infections, but only marginal protection against H3N2 virus infections was observed. Here we show that deletion of two host protease genes,Tmprss2 and Tmprss4, strongly reduced viral spread as well as lung pathology and resulted in increased survival after H3N2 virus infection. Thus, TMPRSS4 represents another host cell factor that is involved in cleavage activation of H3N2 influenza viruses in vivo.

Indexed as

AnimalsBronchiChemokinesCytokinesDisease Models, AnimalDisease SusceptibilityEnzyme ActivationFemaleGene DeletionGene ExpressionHemagglutinin Glycoproteins, Influenza VirusHost-Pathogen InteractionsInfluenza A Virus, H3N2 SubtypeMembrane ProteinsMiceMice, KnockoutChemokinesCytokinesHemagglutinin Glycoproteins, Influenza VirusMembrane ProteinsSerine Endopeptidases

Identifiers

PMID26889029
PMCPMC4836353
OpenAlexW2287495486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.